Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Injection Pen Market: Analysis By Type, By Therapy, By End User, By Region Size & Forecast to 2028" report has been added to ...

AstraZeneca said on 18 September 2026 that the US Food and Drug Administration had accepted the Biologics License Application ...

This article first appeared on GuruFocus. AstraZeneca (NASDAQ:AZN) shares moved lower after the US Food and Drug Administration issued a complete response letter declining approval of a ...

AstraZeneca AZN-0.43%decrease; down pointing triangle said the U.S. Food and Drug Administration rejected an initial submission for its Saphnelo lupus drug in injection form, and vowed to work with ...

AstraZeneca gets a Buy rating as its core business is still growing while a deep late-stage pipeline gives investors multiple ...

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs. The R ...

AstraZeneca plc (NASDAQ:AZN) has been granted approval by the U.S. Food and Drug Administration for a new self-injection format of SAPHNELO (anifrolumab-fnia), enabling adult patients with systemic ...

AstraZeneca’s experimental COPD drug has significantly reduced flare-ups in two late-stage trials, making FDA approval in ...